Hip Fracture

A multidisciplinary care model can reduce the risk for subsequent fractures among adults hospitalized for a hip fracture, according to findings published in Journal of Bone and Mineral Research.

A mobile rehabilitation and health education intervention may enhance recovery and improve physical performance for older patients with hip fractures at 3 months postoperatively, according to published data.

Osteoporosis treatment reduces the risk for hip fractures for older men just as well as it does for older women, according to a study published in Journal of Bone and Mineral Research.

Two fracture risk assessment tools incorporating femoral neck bone mineral density did not outperform femoral neck BMD alone for predicting hip fractures among adults aged 80 years and older, according to study data.

OrthoXel announced FDA 510(k) clearance of the Vertex hip fracture nail. The Vertex hip fracture nail is indicated for use in fixation procedures for various fracture types and patient anatomies, according to a press release.

Children exposed to higher levels of certain endocrine-disrupting chemicals in utero were more likely to develop metabolic syndrome than those who were not, according to findings published in JAMA Network Open.

Among community-dwelling adults with dementia, surgical intervention of femoral head and neck fractures was associated with decreased mortality compared with nonsurgical treatment, according to published results.

Older adults with type 1 or type 2 diabetes who sustain an incident hip fracture have a similar likelihood for a subsequent hip fracture as those without diabetes, according to study data published in Bone.

A once-weekly basal insulin provided noninferior HbA1c reductions compared with once-daily insulins in adults with type 2 diabetes who had never taken insulin as well as those who received multiple daily insulin injections, phase 3 data show.

Older adults who sustain a hip fracture after discontinuing risedronate following at least 5 years of treatment adherence have a higher post-fracture mortality risk than those who continue using risedronate, according to study data.